Autonomic Pharmacology Flashcards

1
Q
fight, fright or flight
sympathetic stimulation
heart rate - \_\_\_\_\_\_\_
feel cold - shunt blood to \_\_\_\_\_\_
breathing - \_\_\_\_\_\_\_ of bronchi
pupils \_\_\_\_\_ - enhance visual acuity
\_\_\_\_ mouth
mobilize body's stored \_\_\_\_\_\_\_
metabolic: \_\_\_\_\_\_\_ and increased \_\_\_\_
-blood vessels: \_\_\_\_\_\_ in skin/mucosa
A
increases
muscles
dilation
dilate
dry
energy
glycogenolysis
BMR
constriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

sympathetic nervous system

  • ________, _______. ________ & _______
  • catecholamines
  • synthesized in _____ tissues
  • stored in _______ vesicles
  • epinephrine = _________
  • secreted from ________
A
epinephrine, norepinephrine, serotonin, & dopamine
neural
synaptic
adrenaline
adrenal gland
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
adrenergic receptors
receptors for epinephrine and norepinephrine
two types of receptors:
\_\_\_\_\_
\_\_\_
\_\_\_ - presynaptic

_____
__
__

what is an alpha 2 stimulant?? and what would it do
-used when beta blockers arent working

A
alpha
a1
a2
beta
b1
b2
clonidine
decrease blood pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adrenergic agonists
agonists
-mimic the action of ___
-sympathomimetics

-stimulate \_\_\_\_\_\_\_ receptors
clinical applications
-shock - \_\_\_\_\_\_\_
-cardiovascular - \_\_\_\_\_\_\_\_; \_\_\_\_\_\_\_; \_\_\_\_; \_\_\_\_\_\_
-\_\_\_\_\_\_\_\_
A
NE
adrenergic
anaphylaxis
bradycardia; hypotension; CHF; cardiac arrest
asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
adrenergic agonists
two types:
1. catecholamines
-\_\_\_\_\_\_\_, \_\_\_\_\_\_, \_\_\_\_\_\_
-\_\_\_\_\_\_\_
2. noncatecholamines
-\_\_\_\_\_\_\_
-\_\_\_\_\_\_\_\_\_(derivative of \_\_\_\_\_\_\_) - increase blood pressure
-\_\_\_\_\_\_\_\_\_ (\_\_\_\_\_\_\_\_)

_______ is ephedrine which is a __ stimulant found in nasal passages which cause them to constrict

A
norepinephrine, epinephrine, dopamine
serotonin
ephedrine
amphetamine
ephedrine
phenylephrine
neo-synephrine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adrenergic agonists

  1. Catecholamines
    - _________ is prototype
    - drug of choice to relieve _______
    - ________ edema in anaphylactic shock
    - _______
    - used in ________
    - metabolized by BOTH _____ and ____
    - not given PO: destroyed by __/__ enzymes
A
epinephrine
bronchospasm
laryngeal
cardiac arrest
hypovolemic shock
COMT and MAO
GI/Liver enzymes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adrenergic agonists

  1. non-catecholamines
    - ______, ______, _______
    - metabolized slowly by ___ and NOT inactivated by ____
    - _____ half lives
    - can be given _____
    - crosses BBB - centrally _____
    - ephedrine available ___
A
ephedrine, phenylephrine, terbutaline
MAO, COMT
longer
orally
active
OTC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inactivating enzymes

  • rapid metabolism by
  • _______ (___)
  • present in liver; intestinal and __synaptic nerve endings
  • ______________ (___)
  • present in liver; intestinal wall and ___synaptic nerve endings
  • ORAL administration is _______ (enzyme present in intestinal wall)
  • _______ requires slow infusion, subcutateous or intramuscular
A
monoamine oxidase (MAO)
pre
catechol-O-methyltransferase (COMT)
post
ineffective 
dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
adrenergic agonists: pharmacological actions
-CNS: \_\_\_\_\_/\_\_\_\_\_/\_\_\_\_\_\_
-CVS: increased \_\_\_\_\_, increased \_\_\_
-vasoconstriction: \_\_\_\_\_\_\_
-eye: \_\_\_\_\_\_/decreased \_\_\_
respiratory: \_\_\_\_\_\_\_\_\_\_
metabolic: \_\_\_\_\_\_\_ and increased \_\_\_\_
blood vessels: constriction in \_\_\_\_/\_\_\_\_\_
A
excitement, stimulation, anxiety
heart rate, BP
epinephrine
mydriasis, IOP
bronchodilatation
glycogenolysis, BMR
skin, mucosa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

adrenergic agonists - clinical uses
beta 1 receptor (heart)
clinical application - mainly on heart
-_______ - ______ to “kick start” a stopped heart, use when all other methods have failed
-____ failure - b1 receptor activation results in a positive _____ effect (force of contraction); thus improved cardiac performance
- shock (profound ________; tissue ______)
-may cause ________ (excessive heart rate)
-may cause _______ (irregular heartbeat

A
cardiac arrest
epinephrine
heart failure
inotropic
hypotension, perfusion
tachycardia
dysrrythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
adrenergic agonist - clinical uses
beta 2 receptor (lungs & uterus)
-activated by
-\_\_\_\_\_\_; albuterol (\_\_\_\_\_\_\_)
clinical application
-asthma - \_\_\_\_\_\_\_
- \_\_\_\_\_\_ (\_\_\_\_\_\_): drug of choice for asthma
delay \_\_\_\_\_ labor
-b2 receptor activation relaxes  uterine smooth muscle (\_\_\_\_\_\_\_)
A
epinephrine
selective agonist
bronchodilatation
albuterol, ventolin
preterm
isoproterenol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

pharmacological effects
cardiovascular system - heart
-mainly __ receptors, some __ and _ effects
beta receptor activation
-increased ______ influx in cardiac cells
-increased _______ activity, positive ______ effect
-increased in conduction velocity in __ node, positive ______ effect
-increased ______ contractility, positive _____ effect

A
b1, b2, a
calcium
pacemaker, chronotropic
AV
Dromotropic
intrinsic 
lnotropic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

pharmacological effects
eye
-__ receptors activate _________ dilator muscles of the iris
-receptor activation causes _______
-_ agonists increase the outflow of _________ from the eye
-__ antagonists decrease the production of aqueous uhmor

A
a
radial pupillary
mydriasis
aqueous humor
b
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmalogical effects
respiratory tract
-__ receptors on bronchial smooth muscle
-activation cause _______
-__ agonists: _______ (ventolin)
-upper resp tract mucosa contain ___ receptors
-stimulation causes _______ action of ______

A
b2
relaxation
b 
albuterol
a1
decongestant 
andrenoceptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pharmalogical effects
gastrointestinal tract

b receptors - activation causes relaxation via _______ and decreased ____ activity in these cells

a2- selective agonists
-decrease muscle activity _____ by reducing the release of _______ and possibly other stimulants in the GIT

A

hyperpolarization
spike
indirectly
acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

exocrine glands

  • salivary glands contains _____ that regulate the secretion of _____ and ___
  • decreased _______/_____
  • _______ sweat glands respond to adrenoceptor stimulants with _____ sweat production
A
adrenoceptors
amylase, water
salivation/xerostomia
apocrine
increased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

pharmacologic
metabolic effects
-adipose cells
- __ adrenoceptor activation increases ____
-increased __________
liver
-________ drugs enhance _______, leading to increased glucose release into the circulation - mainly via __ receptors

A
B, lipolysis
gluconeogenesis
sympathoimetic
glycogenolysis
B
18
Q
USES of adrenergic agonists
anaphylactic shock 
-severe allergy; type I anaphylaxis
clinical signs
-\_\_\_\_\_\_\_ (widespread vasodilation)
-\_\_\_\_\_\_\_\_ & \_\_\_\_\_ of glottis
emergency management
-\_\_\_\_\_\_\_\_ (subcutaneous, IM) just get it in!
-\_\_: increase CO, elevate BP
-\_\_: vasoconstriction leading to an increase in \_\_ & suppress \_\_\_\_
-\_\_: bronchodilatation
A
hypotension
bronchoconstriction, edema
epinephrine
beta 1
alpha 1
BP, edema
b2
19
Q

adrenergic receptor activation mechanisms

  1. _________
    adrenergic agonists
    __________
    isoproterenol
  2. promote ___ release
    - _______
3. \_\_\_\_\_\_\_\_
cocaine
tricyclic antidepressants
imipramine (Tofranil)
amitryptline (Elavil)
doxepin ( Sinequan)
  1. _________
    ____ inhibitors
    - phenelzine (Naril)
    - trancyclpromine (parcate

2 3 AND 4 ARE INDIRECT ACTING ADRENERGIC AGONISTS

A
adrenergic agonists
epinephrine
isoproterenol
NE
amphetamines
inhibit NE reuptake
inhibit NE activation
MAO
20
Q
adrenergic antagonists
-drugs that block \_\_\_\_\_\_ receptors
-two groups
alpha adrenergic blocking agents
-non-selective: block a1 and a2 (\_\_\_\_\_\_\_\_\_, \_\_\_\_\_\_\_\_\_)
selective: block \_\_ only (\_\_\_\_\_, \_\_\_\_\_\_)
beta-adrenergic blocking agents
-non-selective: block b1 and b2 (\_\_\_\_\_\_\_\_\_)
selective blocks \_\_ only (\_\_\_\_\_\_\_)
A
adrenergic 
phentolamine, phenoxybenzamine
a1
prazosin, terazosin
propranolol
b1
atenolol
21
Q

alpha (a) adrenergic antagonists

  • blood vessel (______)
  • essential hypertension: lowers blood pressure via massive _________

__________

  • catecholamine secreting tumor in the adrenal _______
  • in patients with very hypertensive crisis or malignant hypertension (bloodpressure > 180/120 mm Hg)
A

vasodilation
vasodilation
pheocromocytoma
medulla

22
Q

alpha adrenergic antagonists
Raynaud’s disease
-_____ induced disease (_______)
-peripheral vascular disorder, ______ in ___ & _____

A

smoking, nicotine
vasospasm
toes, fingers

23
Q

alpha 1 antagonists
________ (minipress)
-competitive a1 antagonist (selective)
indication - ______

other a1 antagonists

  • _______ (Hytrin)
  • ______ (Regitine)
  • _________ (Dibenzyline)
A
Prazosin
hypertension
Terazosin
Phentolamine
Phenoxybenzamine
24
Q

Beta Blockers

  • competitively block receptors in autonomic nervous system
  • their names end in __
  • beta stimulation produces ________, ________ and ______: beta blockers reverse these effecs
  • effects: initially _______ followed by ______, ____ and _______
  • ______, ______, ________
A
olol
vasoconstriction, bronchodilation, tachycardia
vasoconstriction
vasodilation
bradycardia
bronchoconstriction
propanolol, atenolol, metoprolol
25
Q

beta blockers
- b1 blockage of cardiac tissue results in
-_______ heart rate
-reduced force of _______
-reduced _______ of impulse conduction via ___ node
thus reduced _______

-b2 antagonists
-b2 blockage causes _________
minimal clinical uses

A
decreased
contraction
velocity
AV
cardiac workload
bronchospasm
26
Q
b1 adrenergic antagonists
clinical application of b1 blockage
- \_\_\_\_\_\_\_\_
-\_\_\_\_\_\_
-\_\_\_\_\_\_
-\_\_\_\_\_
-\_\_\_\_\_\_
A
heart failure
hyperthyroidism
migraine
stage fright
glaucoma
27
Q
autonomic nervous system
parasympathetic 
-decreased \_\_\_\_\_\_\_\_\_
- fall in \_\_\_\_\_\_
-constriction of the \_\_\_\_\_ (miosis)
-contraction of the \_\_\_
-watery secretion of \_\_\_\_\_
neurotransmitter
A
heart rate
blood pressure
pupil
GIT
saliva
28
Q

synthesis and storage
-ACh is synthesized from ______ and _____
via __________ (CAT)
-ACh sythensis is a rapid process
-synthesized ACh is transported into vesicles by a transporter
-metabolized by _________ (____)

acetyl Co A - synthesized in the _______
choline - transported from ___ into nerve terminal, by a transporter (carrier)

A
Acetyl-Co-A
choline
choline acetyl transferase
cholinesterase enzyme (AChE)
mitochondria
ECF
29
Q

acetylcholine
effects:
-heart: negative _____ and negative ______ effect. Decrease in ______
-blood vessels: ________ of smooth muscle, ______
-bronchi: _______, ________
GIT: increased ____, _____ and ______
EYE: ____ and ____. decreases ___

A
inotropic
chronotropic
cardiac output
relaxation
vasodilation
bronchoconstriction, bronchospasm
motility, contraction, secretion
miosis, cycloplegia
IOP
30
Q

cholinergic receptors
-receptors for acetylcholine have 2 subtypes
_________ (M) - __________ (Amanita muscaria)

________ (N) - ______ in tobacco

A

muscarinic
poisonous mushroom
nicotinic
nicotine

31
Q

cholinergics

classified as:
-directly acting - act directly on receptor - ______-
-indirectly acting - act by inhibiting the destruction of Ach by ________
further divided into
reversible: ________
irreversible: ________

A

pilocarpine
cholinesterase
neostigmine
organophosphates

32
Q
cholinergics
direct acting
\_\_\_\_\_\_\_\_\_ (used for urinary retention)
-causes contraction of \_\_\_\_\_\_
should not be used in patients with mechanical obstruction of the \_\_\_\_\_ or \_\_\_\_-
\_\_\_\_\_\_\_\_ (used for glaucoma) (\_\_\_\_\_\_)
A
bethanechol
bladder
bladde,r GI tract
pilocarpine
Salogen
33
Q
anticholinergics
-prevent action of \_\_\_\_\_\_\_\_
-\_\_\_\_\_\_ is not affected
-receptor is competitively blocked
-anticholinergics only block 
\_\_\_\_\_\_\_ action ... no effect of nicotinic
-action blocked: \_\_\_\_\_\_, 
\_\_\_\_, \_\_\_\_\_\_
A

acetylcholine
release
muscarinic
smooth muscles, glands, heart

34
Q
belladonna alkaloids
plant sources: \_\_\_\_\_\_\_\_
atropa bella donna means beautiful lady; \_\_\_\_\_\_\_\_\_\_
examples
1
2
A

atropine
pupillary dilation
scopolamine
atropine

35
Q
anticholinergics
atropine and scopolomine
(given \_\_\_\_\_\_\_ or \_\_\_\_\_\_\_)
-\_\_\_\_\_\_\_\_ (Atrovent inhaler/oral)
-\_\_\_\_\_\_\_\_ (spiriva)
A

orally, topical
Ipratropium
tiotropium

36
Q
anticholinergics
Pharmacologic effects
-decreased \_\_\_\_\_\_\_
-smooth muscles: \_\_\_\_\_\_
-\_\_\_\_\_\_\_\_ and \_\_\_\_\_\_\_
-eye: \_\_\_\_\_\_ and \_\_\_\_\_\_\_
-CVS: positive \_\_\_\_\_\_ and \_\_\_\_\_\_\_ effectts result in tachycardia
A
secretions
relaxed
bronchodilation, constipation
mydriasis, cycloplegia
inotropic, chronotropic
37
Q
atropine & scopolamine
GI effects
-secretions: decrease \_\_\_\_\_\_\_
-relax GI muscle except \_\_\_\_\_ and reduce intestinal \_\_\_\_
-decrease \_\_\_\_\_\_ secretion

urinary tract effects
-inhibit the contractility of the urinary bladder and may cause ______ retention

A
salivation
sphincters
motility
gastric acid
urinary
38
Q
adverse effects 
atropine & scopolomine
extensions of the phrmacological effects 
-blurred vision (\_\_\_\_\_)
-photophobia (\_\_\_\_\_\_)
-xerostomia (\_\_\_\_\_\_)
-\_\_\_\_\_\_\_
-\_\_\_\_\_\_\_\_\_ retention
A
cycloplegia
mydriasis
dry mouth
tachycardia
urinary/gi
39
Q

atropine & scopolomine
contraindications
-_____: increased IOP in glaucoma
-prostatic hypertrophy (BPH): urinary ______
intestinal or urinary obstruction: _______ risk
-cardiovascular diseases: ______/______

A

glaucoma
retention
perforation
tachycardia, arrythmias

40
Q

atropine & scopolomine
-respiratory: relax bronchi - therefore used in ________
CNS effects
-_____: causes milkd stimulation followed y slower and longer-lasting sedative effects (CNS depression)
scopolomine is more ____ than atropine
uses: ____________ patches - prevent motion sickness (Transderm V)

A

asthma
atropine
sedating
transdermal scolopamine patches

41
Q

atropine & scopolomine
pre-operative medication: to decrease ____, ___ secretions
-GIT disorders: _____ and increased _____: Ulcers/Traveler’s diarrhea
-Irritable Bowel syndrome: ___________
-Eye exams: ______ measurements
-Motion sickness: ________
-post prostatectomy bladder spasm/ involuntary voiding: _______(_____)

A
bronchial, GIT
hyperacidity
motility
dicyclonine
refractive
scopolomine
oxybutynin (ditropan)
42
Q
nicotine preparations
nicotine inhaler: \_\_\_\_\_\_\_ (nasal)
nicotine chewing gum - \_\_\_\_\_\_\_\_
-\_\_\_\_\_\_ (Varenicline)
-Nicotine transdermal - \_\_\_\_\_\_\_
A

nicotrol
nicorette
champix
nicoderm